MedTrace Logo

SMS Mobile Technology to Improve Early Childhood Vaccine Coverage in Guatemala

NCT02567006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 720

Last updated 2019-09-26

No results posted yet for this study

Summary

This project plans to learn more about whether sending text messages to parents on their mobile phones to remind them when their child is due for his or her next vaccination will improve children getting vaccinated on time.

Conditions

  • Adherence to Vaccination Schedules
  • Timeliness of Vaccination
  • Acceptability of SMS Reminder Program

Interventions

BEHAVIORAL

SMS message

SMS messages will be delivered at 6, 4, and 2 days before the next scheduled date of the primary vaccines for the intervention group

OTHER

Usual care

Health clinic nurse provides regular appointment in the vaccination card with no active reminders

Sponsors & Collaborators

  • Universidad del Valle, Guatemala

    collaborator OTHER

  • Fundacion para la Salud Integral de los Guatemaltecos CU

    collaborator OTHER

  • Ministry of Health, Guatemala

    collaborator OTHER_GOV

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Edwin J Asturias, MD · University of Colorado, Denver

  • Gretchen Domek, MD · University of Colorado, Denver

  • Ingrid L Contreras, MD · University del Valle, Guatemala

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Weeks
Max Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2017-07-07
Completion
2017-07-10

Countries

  • Guatemala

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02567006 on ClinicalTrials.gov